Extended Data Table 5 Estimated mean percent reduction in body weight, weight loss (kg) and change in body mass index from randomization (week 0) and from baseline (week −4) in participants who lost <1.25% of initial weight during the 4-week BT run-in

From: Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial

  1. Data are estimated marginal means (±s.e.) for the intention-to-treat population for the subsample of participants who lost <1.25% of initial weight during the BT run-in (n= 50), derived from linear mixed models (two-sided α = 0.05). BT, behavioral treatment; AOM, anti-obesity medication (phentermine = 15.0 mg d−1).
Back to article page